An oral, liver-restricted LXR inverse agonist for dyslipidemia: preclinical development and phase 1 trial

Xiaoxu Li, Giorgia Benegiamo, Archana Vijayakumar, Natalie Sroda, Masaki Kimura, Ryan S. Huss, Steve Weng, Eisuke Murakami, Brian J. Kirby, Giacomo V. G. von Alvensleben, Claus Kremoser, Edward J. Gane, Takanori Takebe, Robert P. Myers, G. Mani Subramanian & Johan Auwerx
Nat Med (2026). https://doi.org/10.1038/s41591-025-04169-6
Article
Jan 16, 2025
Consortium publication
No